Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors


Why some people with rheumatoid arthritis have pain without inflammation

Written by | 17 Apr 2024

Treatment for rheumatoid arthritis (RA) has come a long way in recent years. In many cases, a battery of medications can now successfully stymy the inflammatory cells that… read more.

Chronic musculoskeletal pain may accelerate brain aging

Written by | 30 Mar 2024

In a study published in Nature Mental Health, scientists from China and the United States have found that individuals suffering from chronic musculoskeletal pain (CMP) may face a higher… read more.

The FDA has approved an expanded indication of the WaveWriter SCS systems for the treatment of chronic low back and leg pain – Boston Scientific

Written by | 15 Feb 2024

Boston Scientific Corporation announced that the FDA has approved an expanded indication of the WaveWriter SCS Systems for the treatment of chronic low back and leg pain in… read more.

Health Canada approves Myfembree to manage moderate to severe pain associated with endometriosis – Sumitomo Pharma Canada + Pfizer Canada

Written by | 26 Oct 2023

Sumitomo Pharma Canada, Inc. and Pfizer Canada announced that Health Canada has granted a Notice of Compliance (NOC) for Myfembree (Relugolix, estradiol and norethindrone acetate tablets) for the… read more.

Can cognitive-behavioral therapy lessen fibromyalgia pain?

Written by | 21 Sep 2023

In a recent randomized clinical trial of patients with fibromyalgia, cognitive-behavioral therapy (CBT)—which uses structured techniques to alter distorted thoughts and negative moods—was superior to a matched education… read more.

Inceptiv spinal cord stimulator with closed-loop sensing to treat chronic pain receives CE Mark – Medtronic plc

Written by | 29 Aug 2023

Medtronic plc has received CE (Conformité Européenne) Mark approval for its Inceptiv closed-loop rechargeable spinal cord stimulator (SCS). It is the first Medtronic SCS device to offer a… read more.

EU approves Aquipta for prophylaxis of migraine – AbbVie

Written by | 23 Aug 2023

AbbVie announced that the European Commission has approved Aquipta (atogepant) for the prophylaxis of migraine in adults who have four or more migraine days per month. The approval… read more.

Oxycodone prescriptions after delivery not linked to longer-term opioid use compared to codeine prescriptions

Written by | 2 Aug 2023

Over the last 10 years, there has been a shift to fewer codeine prescriptions and an increase in prescriptions for stronger opioids, such as hydrocodone, hydromorphone and oxycodone… read more.

Patients with rheumatic and musculoskeletal conditions vulnerable to long term opioid use

Written by | 19 May 2023

Patients with rheumatic and musculoskeletal conditions are vulnerable to long term opioid use, with up to 1 in 3 of those with rheumatoid arthritis or fibromyalgia, who take… read more.

New study questions the efficacy of many osteoarthritis treatments

Written by | 29 Apr 2023

Recruiting osteoarthritis patients with a lot of pain to clinical studies, may give incorrect results if the researcher does account for the natural variation in pain that occurs…. read more.

Vitamin D ineffective for statin-related pain

Written by | 30 Nov 2022

Statin-related pain is not reduced by vitamin D therapy, researchers reported on Nov. 23, 2022 in JAMA Cardiology. As background, the authors noted, “Statin-associated muscle symptoms (SAMS) are… read more.

Pain is no joke in labor, but withdrawing laughing gas has no ill effects

Written by | 19 Sep 2022

Birthing women denied nitrous oxide (‘laughing gas’) to relieve labour pain during the COVID-19 pandemic have turned to opioids instead, without any adverse outcomes for mother or child,… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.


You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.